TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Novartis Sverige AB
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
1,976,097
|
1,743,677
|
1,646,843 |
| Financial expenses |
12,110
|
9,138
|
6,344 |
| Earnings before taxes |
56,781
|
61,774
|
65,630 |
| EBITDA |
70,614
|
73,587
|
74,660 |
| Total assets |
742,443
|
699,168
|
600,820 |
| Current assets |
728,579
|
684,223
|
583,802 |
| Current liabilities |
341,152
|
324,138
|
290,775 |
| Equity capital |
131,877
|
100,101
|
114,347 |
| - share capital |
5,000
|
5,000
|
5,000 |
| Employees (average) |
189
|
206
|
216 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
17.8%
|
14.3%
|
19.0% |
| Turnover per employee |
10,456
|
8,464
|
7,624 |
| Profit as a percentage of turnover |
2.9%
|
3.5%
|
4.0% |
| Return on assets (ROA) |
9.3%
|
10.1%
|
12.0% |
| Current ratio |
213.6%
|
211.1%
|
200.8% |
| Return on equity (ROE) |
43.1%
|
61.7%
|
57.4% |
| Change turnover |
232,420
|
96,834
|
-5,957 |
| Change turnover % |
13%
|
6%
|
0% |
| Chg. No. of employees |
-17
|
-10
|
-12 |
| Chg. No. of employees % |
-8%
|
-5%
|
-5% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.